Study to Assess the Effect of Long-Term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 (034OLE)
An Open Label Extension Study of Voxelotor (GBT440) Administered Orally to Participants With Sickle Cell Disease Who Have Participated in Voxelotor Clinical Trials
Category & Conditions: Rare Diseases
Medicine: OXBRYTA(VOXELOTOR)
ClinicalTrials.gov Identifier (NCT): NCT03573882
Protocol ID: C5341022 (GBT440-034)
Open Plain Language Summary Result:
Click here